AIRLINK 196.24 Increased By ▲ 2.68 (1.38%)
BOP 10.06 Increased By ▲ 0.11 (1.11%)
CNERGY 7.88 Decreased By ▼ -0.05 (-0.63%)
FCCL 40.56 Decreased By ▼ -0.09 (-0.22%)
FFL 17.14 Increased By ▲ 0.28 (1.66%)
FLYNG 27.59 Decreased By ▼ -0.16 (-0.58%)
HUBC 134.00 Increased By ▲ 1.42 (1.07%)
HUMNL 14.05 Increased By ▲ 0.16 (1.15%)
KEL 4.68 Increased By ▲ 0.08 (1.74%)
KOSM 6.70 Increased By ▲ 0.08 (1.21%)
MLCF 47.65 Increased By ▲ 0.05 (0.11%)
OGDC 216.20 Increased By ▲ 2.29 (1.07%)
PACE 6.97 Increased By ▲ 0.04 (0.58%)
PAEL 42.25 Increased By ▲ 1.01 (2.45%)
PIAHCLA 17.39 Increased By ▲ 0.24 (1.4%)
PIBTL 8.54 Increased By ▲ 0.13 (1.55%)
POWER 9.65 Increased By ▲ 0.01 (0.1%)
PPL 185.00 Increased By ▲ 2.65 (1.45%)
PRL 42.70 Increased By ▲ 0.74 (1.76%)
PTC 25.14 Increased By ▲ 0.24 (0.96%)
SEARL 105.90 Decreased By ▼ -0.94 (-0.88%)
SILK 0.99 No Change ▼ 0.00 (0%)
SSGC 44.11 Increased By ▲ 4.01 (10%)
SYM 17.85 Increased By ▲ 0.38 (2.18%)
TELE 9.02 Increased By ▲ 0.18 (2.04%)
TPLP 13.05 Increased By ▲ 0.30 (2.35%)
TRG 67.35 Increased By ▲ 0.40 (0.6%)
WAVESAPP 11.54 Increased By ▲ 0.21 (1.85%)
WTL 1.83 Increased By ▲ 0.04 (2.23%)
YOUW 4.05 Decreased By ▼ -0.02 (-0.49%)
BR100 12,212 Increased By 167.3 (1.39%)
BR30 37,011 Increased By 430.7 (1.18%)
KSE100 115,104 Increased By 1066.2 (0.93%)
KSE30 36,179 Increased By 384.2 (1.07%)
Business & Finance

Walgreens forecasts 2021 profit growth after Q4 earnings beat

  • The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.
Published October 15, 2020

Drugstore chain Walgreens Boots Alliance Inc said on Thursday it expects profit to grow in single digits in 2021, after posting a better-than-expected fourth-quarter profit, helped by higher sales at US pharmacies.

Shares of the largest US drugstore chain rose 2.8pc to $36.93.

The company said it expects strong adjusted profit growth in the second half of 2021, as impact of the COVID-19 pandemic subsides, and supported by its recovery plans.

Last quarter, the company suffered a significant decline in footfall in its UK-based retail pharmacies, and resorted to store closures, job cuts and suspension of share repurchases.

Same-store sales at the company's retail pharmacy division in the United States rose 3.6pc from a year earlier.

Excluding items, Walgreens earned $1.02 per share, beating analysts' expectations of 96 cents per share.

Comments

Comments are closed.